Back to BetterHealthGuy

Episode #225: The Long COVID Puzzle with Dr. Robin Rose, DO

BetterHealthGuyDecember 1, 20251h 54m
In a Nutshell

Dr. Robin Rose explains long COVID (and post-vaccine conditions) as driven by SARS-CoV-2 acting as a bacteriophage in the gut, producing spike protein and toxin-like peptides that cause cellular senescence, immune dysregulation, endothelial damage, microclotting, mitochondrial dysfunction, neuroinflammation, and reactivation of latent viruses across all organ systems. Key mechanisms include spike binding to multiple receptors (beyond ACE2), furin cleavage, glycocalyx destruction, and persistent circulating spike detectable via mass spectrometry and provocation testing. Treatments emphasize gut restoration (ozonated glycerin, phage killers), spike binders/senomorphics (Vitalinals 9/Medicinals 9 with quercetin, EGCG, fucoidan), mitochondrial support (SS-31, ketones), mast cell stabilizers (amlexanox, nicotine patches), neuroprotection (melatonin, ProdromeGlia), and advanced therapies like EBOO, prioritizing binders before senolytics to safely clear spike without forming neurotoxic fibrils; prophylaxis includes nasal sprays, zinc/Vit D/C, and avoiding repeated exposures.

AI-Generated Notes

These notes were generated by AI and may contain inaccuracies.

Episode #225: The Long COVID Puzzle with Dr. Robin Rose, DO

Welcome to Better Health Guy blogcasts, empowering your better health. The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health related decisions with your own personal medical authority.

Hello everyone and welcome to episode 225 of the Better Health Guy blogcast series. Today's guest is Dr. Robin Rose and the topic of the show is the long COVID puzzle. Dr. Robin Rose, author of the 28-day gut fix, is a double board-certified specialist in gastroenterology and internal medicine specializing in gut health and long COVID. She is founder and CEO of Terrain Health where she practices next generation precision health care integrating systems biology with an innovative approach that requires a deep understanding of each person's biochemical, genetic, and lifestyle factors. Her comprehensive approach prioritizes patient-centered care by creating health care interventions that are more precise, personalized, predictive, participatory, and preventative. Her philosophy is deeply rooted in healing her patients from the inside out so that they will age less.

Dr. Robin received her bachelor's degree in behavioral neuroscience from Lehigh University, graduating with honors. She then went on to obtain her master's degree in neuropsychology from New York University. Dr. Robin received her medical degree from the New York College of Osteopathic Medicine, graduating with honors and was inducted into the Sigma Alpha Osteopathic National Honor Society. She did her post-graduate training in internal medicine followed by a fellowship in gastroenterology and hepatology at Beth Israel Medical Center in New York City and holds board certifications in both disciplines. Dr. Robin practices longevity medicine, teaching women and men how to achieve their best selves by restoring and optimizing gut health, balancing hormones, and proactively managing metabolic, cardiovascular, and brain health. Maximizing these outcomes will pave the way for optimal health span and performance and looking and feeling your best.

The topic of long COVID is arguably the most important topic to be discussed today. Millions of people are struggling with complex chronic illnesses in ways that we have never before observed. Today I'm excited to have a personal hero, Dr. Robin Rose, here with us to talk about her deep dive into the long COVID puzzle.

Thank you so much for having me. I'm delighted to be with you.

At the beginning of the pandemic, Dr. Rose was following it from early January because her husband had business associates in China. She knew it was coming. In early March, she went on a business trip to New York despite hesitation, returned around March 3rd or 5th, and encountered a coughing passenger on the plane. Four days later, while scoping in the GI suite doing colonoscopies, she got a bad upper respiratory infection that hit her like a Mack truck. She doesn't usually get sick. Her husband was the only other person to get it; the kids didn't. The hospital wouldn't let her return to work.

She became obsessed with COVID, watching webinars worldwide, listening to renowned virologists, and wrote a primer on treating long COVID using natural compounds like quercetin, curcumin, melatonin, omegas, vitamin C, and obscure polyphenolic compounds. She wanted to treat herself, loved ones, family, and friends. She thought she might die from COVID due to the unknowns. Her test came back negative after delays. This started her journey to opening Terrain Health by fall 2020.

By fall 2020, doing advanced biomarkers and next-generation sequencing of the gut microbiome, she saw disturbing changes evolving into early 2021. With vaccines, medical news feeds censored questioning content from renowned scientists within 24 hours. Early vaccinated patients showed changes in white blood cell counts, ferritin levels, loss of Bifidobacteria species, and complete depletion of Actinobacteria in gut sequencing.

She avoided vaccination but got one shot due to hospital faculty role, ending up in the ER for 4 hours with a major reaction. She saw bizarre patient issues like herpes reactivation and Bell's palsy at unprecedented rates.

One of the first things is perspective on what long COVID is: spike protein toxicity, persistent SARS-CoV-2, unmasker of Epstein-Barr, Bartonella, Mycoplasma, varicella, higher shingles incidence.

It's all the things you said. It's all the things and it's very well documented. This is not like we're guessing or hypothesizing.

SARS-CoV-2 is a bacteriophage: takes up residence in gut microbiome bacteria, visible under electron microscope with hundreds/thousands of virions inside bacteria. Bacteria then secrete toxin-like peptides, neurotoxic, impacting any organ (heart, brain, lungs, kidneys). Research with Dr. Simone Cristoni and Carlo Brogna in Italy; Carlo discovered bacteriophage aspect.

Gut is ground zero. Significant intestinal permeability, dysbiosis, plus toxin secretion. Bacteria manufacture spike protein (bacterial vs. human origin via mass spectrometry). Spike from virus inside bacteria or mRNA inside bacteria. Spike protein binds to over two dozen host cell receptors (not just ACE2), gains cell access, renders cells senescent (age accelerant). Spike inhibits autophagy, overrides it.

Brusaferro and Cristoni found circulating spike protein in blood of vaccinated patients over 6 months out in >50%. Spike doesn't live in blood; seeks cell entry. Once inside cell:

  • By itself: senescent, produces inflammatory cytokines, SASP (senescence-associated secretory phenotype) affects adjacent cells.
  • With mRNA/lipid nanoparticle or virus: cell becomes spike-producing factory.

Treatment: complex, step-wise. Use senomorphics to save adjacent non-spike cells (don't kill with senolytics yet). Methodical clearing of spike protein.

Massive cellular senescence (esp. immune senescence), immune dysregulation (macrophages, Langerhans cells impacted per Shante Sinatra). Reactivates latent viruses (Lyme, Bartonella, Epstein-Barr, herpes) because immune homeostasis lost; everything chaotic. Restore gut microbiome, gut-immune axis, immune system to control. Downstream effects of spike/persistent virus.

People tolerant of moderate mold/mycotoxin exposure pre-long COVID now need environmental improvements (bucket theory). We live in a toxic soup (blue light, LED, air, toxins, PFAS); spike is "beast of toxins", not from this world, pushes over threshold. Amplifies chronic disease epidemic: undefined neurodegenerative, autoimmune diseases, elevated ANAs, autoantibodies, molecular mimicry.

Overlap with chronic Lyme, mold illness, heavy metals, toxicity. No unique hallmarks; all age groups similar.

I don't really think of it as like long COVID or long vax or whatever. I call them post-COVID conditions and post-vaccine conditions because everyone's condition could be different.

Spectrum: chronic fatigue, brain fog, post-exertional malaise, headaches, shortness of breath, MCAS, POTS, neuropathy. Or clots, stroke, heart attack, turbo cancer, autoimmune in previously healthy. Use blood work patterns, clinical/biochemical understanding, research measuring spike in specific cells via systems biology to find weakest link, resolve symptoms.

No one definition of 200 symptoms; manifestations in young/healthy.

All: wild-type only, vaccine only (mRNA or not), wild-type then vaccine (worse), vaccine then virus (worse), relapses with subsequent infections. Exposure to spike/virus in gut worsens leaky gut/brain, organ systems, autonomic nervous system. Precision medicine based on epigenetics, genetics, biological state at exposure.

Subsequent exposures cause relapse; becomes relapsing remitting mitochondrial disorder. Patients 80-100% better relapse on any insult (mental/emotional/physical). Build immune resilience, metabolic resilience, mitochondrial resilience.

Even post-COVID, avoid repeated exposures to minimize chronic illness; avoid shedding. Virus more insidious.

The virus is terrible; every exposure produces trillions of spike protein. Studies show asymptomatic or mild COVID infections cause brain changes: decreased cerebral blood flow, alterations in gray and white matter, low-grade neuroinflammation. Many people, even young ones, experience brain fog, memory issues, poor attention. Middle-aged women often blame perimenopause or menopause, but imaging proves post-infection changes even in unaware or mildly symptomatic cases. Repeated exposures worsen this.

Blood tests on screening patients (not seeking post-COVID care) show elevated pTau 217, low Aβ42/40 ratios, TGF-β1 at 20,000–40,000+. Without intervention, they may develop Alzheimer's, dementia, or neurovascular dementia years later. This is serious, yet unscreened.

ACE2 receptor is relevant (lungs, gut, body-wide) but a millionth of the issue; overfocus ignores others. Virus binds neuropilin-1, DPP4, and many receptors (heart, brain, cells body-wide). Furin cleavage site is gain-of-function: aggressively cleaves spike into pathogenic S1 (drives disease) and S2 subunits, exponentially higher than prior SARS. Receptor binding domain (RBD) in S1 binds host receptors with high affinity.

Treatment Goals

Inhibit furin cleavage (furin/fusion enzyme inhibitors) and block RBD (neutralizers, higher-affinity receptor binders). Use spike binders for free spike. Protect healthy cells post-senolytic therapy to prevent unbound spike access. Senolytics/autophagy support pre-COVID differed; now, high spike burden risks overwhelming with senolytics, causing harm. Tailor carefully by burden.

Antibody tests unreliable: persistent spike production keeps spike antibodies high (Quest >2500, LabCorp >25,000). Nucleocapsid (N) antibodies indicate wild-type infection (wane 6–8 months), but persistent N suggests ongoing virus. Indirect; pair with history/clinical picture.

Direct mass spectrometry measures spike sequence/amino acids, differentiates wild-type vs. vaccine spike (via 2-proline PP substitution). Available research-based/wellness test via Wellness Journey US.

Provocation testing: Baseline blood, then senolytics provoke intracellular spike release (vaccine intracellular). Post-provocation (2 hours): assess dump volume, immune efficacy (e.g., macrophages phagocytosing spike). Low baseline → high post = high burden, poor immunity. Detects viral, vaccine, bacterial-origin spike; toxin-like peptides (unique blueprint, personalizes treatment). Future: map spike location (mitochondria, neurons, skin, cardiac, kidney cells) for targeted therapy.

Provocation uses senolytics (dosed by age); prior binders masked results. Post-test: Vitalinals 9 (9 polyphenolics: 8 binders, 4 senolytics, senomorphics, RBD blockers, furin inhibitors; synergize on spike pathways).

NLR (neutrophil-lymphocyte ratio), LabCorp cytokine 13-panel useful. Radiance long hauler panel uninformative (misses non-positive cases; spike affects all immune cells: B, T-CD4/CD8, macrophages, dendritic, monocytes). Mass spec shows vaccine in all lineages; systems biology lens needed.

90% patients score 3–4/4 on microclot testing (Dr. Jordan Vaughn, Alabama; tracks to <2.5). No triple anticoagulants (dangerous, band-aid). Root: spike damages endothelium (endotheliitis), glycocalyx, activates cascades. D-dimer elevated in 7–8/10 screened patients; population has pathologic microclotting.

Vitalinals 9, binders (pentacin, fucoidan) repair glycocalyx, weak anticoagulants. Remove spike, optimize downstream: 2/3+ clear microclots on retest.

No nattokinase/lumbrokinase: neutrophil elastase (activated post-spike) forms Hammarström fibers (neurotoxic fibrils: tau, amyloid-beta+ per Per Hammarström/Sofia Nestrom studies). Enzymes may fuel this; avoid until proven safe.

Endothelial/Glycocalyx Support

Spike targets vascular endothelium. Glycocalyx damaged (evolving variants worsen despite lower pathogenicity). Tools: Vitalinals 9, pentacin, fucoidan (repair glycocalyx, anticoagulants).

With evolving variants, even though they are less pathogenic and cause fewer symptoms, they have a much higher affinity to destroy the glycocalyx. This is another reason to avoid the virus. Destruction of the glycocalyx and enhancement of heparanase released with newer variants create major vascular problems for many people. Without destruction of the glycocalyx or endothelium, there is no real disease. Because it happens easily and frequently, it drives a lot of disease. Ensure patients have a healthy glycocalyx and no underlying smoldering endotheliitis. Polyphenol compounds help block this and heal/protect the glycocalyx, supported by tons of studies. Glycosaminoglycans like chondroitin sulfates and fucoidan restore health and balance to the glycocalyx. Prevention is crucial, as newer variants have higher affinity for cardiomyocytes, neurons, and endothelial cells.

Fucoidan plays a significant role in long/post-COVID. SARS-CoV-2 or spike activates mast cells in some people, similar to mold, mycotoxins, Bartonella, parasites, EMFs. Patients benefit from interventions to stabilize mast cells. More POTS dysautonomia than ever, driven by COVID/spike, treated specifically while addressing root causes. Hypermobility/EDS is increasingly an issue; mast cell mediators like elastase may break down connective tissue. Increase in hypermobility/EDS seen in patients.

EDS/hypermobility predisposes patients earlier; they have histories of tearing tendons, orthopedic injuries, hypermobility on a spectrum from hypermobile to Ehlers-Danlos (often misdiagnosed, diagnosis of exclusion). These patients were setups, and COVID pushed it forward. Mast cells release after platelet activation from low-grade endotheliitis, releasing massive histamine, cytokines, chemokines, and TGF-beta (40% from activated platelets/mast cells). This creates a chaotic environment like learned behavior; break the vicious cycle. Mast cell activation overlaps with dysautonomia/POTS; mast cells aggravate POTS symptoms (blood pressure fluctuations high/low, heart rate fluctuations, orthostatic tachycardia, flushing, rashes, neuropathy, dizziness, lightheadedness, headache). All post-COVID patients have dysautonomia driven by spike protein, macrophage activation, vagal nerve impact, gut-immune axis disruption—no need for tilt test or positive histamine/tryptase; clinical history diagnoses it (80-90% have mast cell activation with dysautonomia). Be a detective with good history-taking. Mantra: feel better to get better; band-aid upfront.

Use nicotine patch upfront to control dysautonomia, knock spike off acetylcholine receptors while addressing mitochondria. SS-31 (peptide). Amlexanox (repurposed drug, safe, used in Japan since 1980s for atopic dermatitis/asthma in children): mast cell stabilizer, great for neuroinflammation, cardiovascular inflammation, insulin sensitizer. Use with H1/H2 blockers short-term, then Amlexanox as bridge. Low-dose naltrexone works for mast cell activation. Personalize based on patient needs to help tolerate deeper treatments.

Neuroinflammation huge due to spike protein destroying blood-brain barrier (high affinity for astrocytes, pericytes). Destroys glymphatic system (brain toxin drainage, especially at night). Dysautonomia/insomnia prevents repair. Melatonin great for NLRP3 pathway, restores lymphatic system/blood-brain barrier (tons of studies). Plasmalogens (ProdromeGlia by Dr. Goodenweave, day product). SS-31 for mitochondrial dysfunction reversing neuroinflammation. Medicinal nasal spray with polyphenols, melatonin pushes across blood-brain barrier. Root cause: remove spike to stop recurring neuroinflammation from neurotoxins, neurotoxic fibrils (alpha-synuclein, pTau, beta-amyloid), microglial activation—vicious cycle.

Start high doses of ProdromeGlia upfront, then based on brain fog/neuroinflammatory biomarkers, continue GA and add lower dose ProdromeNeuro after one bottle high-dose GA.

Rapid onset cognitive issues in young people. Increase in beta-amyloid, pTau, alpha-synuclein; spike impacts glymphatic drainage. Already seeing tsunami: elevated markers with/without symptoms, uptick in young Parkinson's, horrible brain fog/dementia/forgetfulness/cognitive decline. New spectrum of neurodegenerative diseases: mishmash of neurotoxic fibrils, not fitting classic ALS/Parkinson's/MS (e.g., motor neuron issues not progressing like ALS, atypical tremors). Atypical MS/Parkinson's—consider post-COVID high on list.

Every patient has mitochondrial dysfunction; spike directly/indirectly impacts. Poor mitochondrial reserve. Spike damages cardiolipin, maintaining inner mitochondrial membrane/matrix for ATP. Spike accelerates aging: fewer cristae folds reduce surface area for complexes I-IV, producing fewer/aged mitochondria. Support infrastructure first: SS-31 restores cardiolipin/inner membrane for functional mitochondria. Then: L-carnitine, alpha-lipoic acid, creatine (high doses), certain amino acids, ketones (KetoNT Pro by Longevity Launch, bioidentical, skips glycolysis). Methylene blue later, not upfront (cart before horse). Learned from colleagues Dr. Betsy, Cynthia Cutler, Leonard Positano at New U Life—still evolving dosing/timing/personalization.

NAD crazy; too much exogenous NAD overflows pathways, produces toxic metabolites. Use biofeedback loop to restore own NAD pools. 1-MNA (from Poland) blocks enzyme NAMPT, pairs with apigenin (blocks CD38), avoids overflow without excess NAD. NAD IV often makes 50-2/3 patients feel awful; use sparingly/later if needed.

Early pandemic: low ferritin but normal/high iron (opposite of classic iron deficiency). Rare high ferritin unless acute infection. HMOX overwhelmed post-COVID (per Bob Miller); needed to store iron as ferritin, so underutilized there. Don't supplement iron (makes it higher, deposits in soft tissues/organs). Treat root (remove spike, address downstream) to rebalance, free HMOX for ferritin. Normal/high iron with low ferritin common.

Seeing higher cancer incidence. Proof: at least 10% increase per Josh Sterling's group (nonprofit insurance collaborative); high death rates in young/insured, escalation in disability never seen before. If you look at the health care stocks,

Health care companies are paying out significantly more for chronic conditions in middle-aged and young people, with claims down by 50% or more. Exponential increase in cancers post-pandemic. Lung cancer has been declining for 1-1.5 decades prior; excluding it reveals huge increases in other cancers, pinpointed to specific age groups. Driven by interferon impact, p53 tumor suppressor gene significantly impacted by spike protein, immune dysregulation, and immune senescence.

All patients undergo full environmental assessment including EMFs. EMF exposure plays a role in post-COVID recovery; some patients need to reduce it.

For ultra-sensitive patients with significant dysautonomia, cortisol dysregulation, use limbic system retraining, vagal tonification, autonomic nervous system calming to create safety (per Dr. Neil Nathan). Upfront: nicotine patch for mitochondrial health/balance, SS31, vagus nerve toning, HPA axis dysregulation support.

Shifted away from antibiotics like amoxicillin or Zithromax with zyvox due to destroyed microbiome, intestinal permeability, dysbiosis. Learned about ozonated glycerin (OG) at AOT conference (Jim Bridge/Dr. Bridge). OG is H2O2; Japanese studies for diabetes show gut/microbiome impact. Kills lipid-coated (COVID) and non-lipid enveloped viruses, RNA viruses.

Absorbed in first part of small intestine orally; mix with chia seeds and liquid to push to large intestine. Japanese studies: kills bad bacteria, fungi, protozoa, viruses; spares good bacteria. Combine short course with BHT (butylated hydroxytoluene) (500x below LD50; food preservative misinterpretations). BHT kills bacteriophages, lipid enveloped viruses.

Dr. Carlo Bronia with Jookim Gerlock developing Bronia pills for phages/gut. Then restore: fecal antibiotics (shower metabolites for leaky gut, feed good bacteria), specific probiotics (for metabolites), zinc, C, D.

Average 12-30 toxin-like peptides. Upfront: larazotide (500 mcg 3x/day, high doses) to seal leaky gut, prevent leakage during gut treatment. Target phages first to stop production. Repair intestinal mucosal barrier. EBOO (Strato system): published in Journal of Mass Spectrometry; 7 filters (5 provoked patients) riddled with toxin-like peptides and spike (filtered by Stratos filter), decreases burden.

High-level: block receptors, liberate/bind/remove spike, antiviral support, senolytics for senescent cells. Senolytics remove entire senescent cell with spike payload or break it up—need binders when using senolytics. Start low/slow with viscum 9 (senomorphic at low dose to save adjacent cells impacted by SASP), then destroy senescent cells/ senescentia holding spike/mRNA/virus.

Chelators and binders bind spike for removal (not receptor blockers). Keep spike intact to avoid exposing epitopes forming homron fibers/neurotoxic fibrils—avoid bromelain, nattokinase, lumbrokinase (theoretically chop spike).

  • Polyphenolics: EGCG, quercetin (8 binders)
  • Fucoidan
  • Zeolite
  • Silica
  • New Sequester (Medicinals 9): combines binders/natural compounds with high affinity.

Blocks 300 pathways (virus/spike). Contains quercetin, rutin, EGCG, luteolin, apigenin, curcumin, hesperidin, licorice, black pepper (polyphenols, binders, senolytics).

  • Prophylactic/maintenance: 2 tsp/day or M/W/F.
  • Exposure/early symptoms: daily, double dose.
  • Acute: ½-1 bottle/day.
  • Long COVID: work up to 2 tsp AM + 3 tsp PM (low/slow; GI/brain fog/herxing possible due to bioavailability, detox).

Upfront: homeopathy (Pana or Gona deep cleanse) to open liver/kidney/lymphatic; larazotide, binders (patients congested, poor methylation/detox).

  • Sequester: binder.
  • Senolytics: autophagy support for senescent cells.
  • Omega-3s: potential spike binders. Binder/sequester before liberating with senolytics (except provoke testing: senolytic first, then V9 to avoid skewing data).

Nasal hygiene as essential as dental. Prophylactic daily nasal sprays.

  • Medicinals 9 spray (launching soon; using for years): 1 spray each nostril AM/PM.
  • Neural Essence: similar to V9 spray + melatonin (repairs blood-brain barrier, lymphatics, astrocytes); 1-2 sprays each nostril nightly (prophylactic/treatment; every 2-3 hrs acute).
  • 10% OG nasal spray (diluted sterile water): 1 spray each nostril AM/PM, piggyback V9.

Pre-flight/crowds: spray OG/V9. Inhibits virus attachment to nasopharyngeal mucosal cells (first defense vs. coronaviruses, RNA viruses, flu).

Nebulize 5-10% OG (start 5%).

Used early (4 years ago) for spike detachment (RBD), lowers viral load (in vitro). No longer for long COVID (far-out patients, new variants). Prophylactic/acute (any viral): Brazilian study (88k patients, Pierre Kory, ~2021): 0.2 mg/kg 2x/week (Mon/Tue every other week; 4 pills/month). Sick: double/triple to 0.4-0.6 mg/kg duration of illness (reduces days if prophylactic).

Zinc, C, D daily. Gut maintenance: fecal antibiotics (6-9 months, then PRN), new butyrate, KPV, BPC-157, larazotide (infections enter via gut). Pentosan polysulfate/pentosan: spike binder, nasal spray (protects nasopharynx, penetrates BBB).

EBOO filters spike/toxin-like peptides. TPE (therapeutic plasma exchange): effective anecdotally/studies for long COVID symptomatic relief, but uses albumin/pooled products unscreened for virus/spike.

The problem with TPE (therapeutic plasma exchange) is using albumin or pooled blood products not screened for virus or spike protein. Theoretically, this could reintroduce contaminants into the patient. Initial filtering effects may make patients feel better by removing garbage, but long-term effects are uncertain. EBOO uses a contained system filtering the patient's own blood without pooled products. Similarly, stem cell therapy, PRP, and related autologous therapies use the patient's own blood. However, if the patient has persistent spike protein or virus, this may not be beneficial. Spike protein persists in stem cells, exosomes, and can be tested for. These issues need study, and lack of screening is concerning.

Dr. Rose prioritizes good sleep as a foundational pillar for regeneration, repair, and detoxification, especially brain lymphatic system. She moves as much as possible but admits needing more sweating to eliminate toxins. She eats decently and manages stress better now after personal challenges. Supplementation includes:

  • Medicinal 9 nasal sprays daily
  • Ozonated glycerin (at least 1 tsp daily for maintenance)
  • High-dose zinc
  • Vitamin D with K2
  • Vitamin C
  • Vitamin E daily
  • B complex (methylated folate and B12 due to MTHFR mutation)
  • Magnesium at night
  • Melatonin nightly for benefits beyond sleep
  • Sun Balance by US Enzymes (contains luteolin, quercetin, PEA) for spike protein and COVID effects

She suspects personal struggles with spike protein and virus exposure, like frequent migraines (worsened from pre-existing intermittent ones post-exposure/vaccine). Doctors are the worst patients; she has an IV infusion center with EBOO but underutilizes it for herself. She tries major autohemotherapy with hemolumin, high-dose IVC with advanced nutritional therapeutics, and Cerebrolysin IV for neuroinflammation.

Host plans to email Dr. Rose's staff to book her into the IV lounge, praising her as a gift and treasure. Her contributions to humanity navigating current challenges are critical and life-changing. Dr. Rose thanks him warmly.

To learn more, check show notes links. Leave positive ratings/reviews to reach broader audience. Support at betterhealthguy.com/donate. Newsletter at betterhealthguy.com/newsletters. Follow on Facebook, Instagram, X, TikTok as Better Health Guy. Episodes on Apple Podcasts, Spotify, Amazon Music, YouTube, Odyssey. Thanks for listening to Better Health Guy blogcast with Scott.

Keep BetterHealthGuy in your library

Save the videos and channels worth coming back to, and find them again in one place.